Current Opinion in Clinical Nutrition & Metabolic Care,
Journal Year:
2022,
Volume and Issue:
26(2), P. 120 - 128
Published: Nov. 24, 2022
Purpose
of
review
Biomarkers
proposed
to
provide
prognosis
or
determine
the
response
enteral
nutrition
have
been
assessed
in
a
number
experimental
and
clinical
studies
which
are
summarized
current
review.
Recent
findings
There
several
pathophysiological
mechanisms
identified
could
biomarkers
nutrition.
Several
studied,
most
them
insufficiently
none
has
made
its
way
practice.
Available
mainly
simple
association
biomarker
with
outcomes,
but
less
focused
on
dynamic
changes
levels.
Importantly,
pathophysiology
features
gastrointestinal
dysfunction,
including
feeding
intolerance,
also
needed
explore
potentially
providing
specific
biomarkers.
Not
only
an
any
adverse
outcome,
rationale
for
repeated
assessment
assist
treatment
decisions
during
course
illness
is
warranted.
Summary
no
currently
available
reliably
practice,
identification
such
would
be
valuable
decision-making.
Critical Care,
Journal Year:
2023,
Volume and Issue:
27(1)
Published: March 28, 2023
The
gut
microbiome
plays
a
pivotal
role
in
the
progression
of
sepsis.
However,
specific
mechanism
microbiota
and
its
metabolites
involved
process
sepsis
remains
elusive,
which
limits
translational
application.In
this
study,
we
used
combination
untargeted
metabolomics
to
analyze
stool
samples
from
patients
with
enrolled
at
admission,
then
microbiota,
metabolites,
potential
signaling
pathways
that
might
play
important
roles
disease
outcome
were
screened
out.
Finally,
above
results
validated
by
transcriptomics
analysis
an
animal
model
sepsis.Patients
showed
destruction
symbiotic
flora
elevated
abundance
Enterococcus,
experiments.
Additionally,
high
burden
Bacteroides,
especially
B.
vulgatus,
had
higher
Acute
Physiology
Chronic
Health
Evaluation
II
scores
longer
stays
intensive
care
unit.
intestinal
transcriptome
CLP
rats
illustrated
Enterococcus
Bacteroides
divergent
profiles
correlation
differentially
expressed
genes,
indicating
distinctly
different
for
these
bacteria
Furthermore,
exhibited
disturbances
amino
acid
metabolism
compared
healthy
controls;
namely,
tryptophan
was
tightly
related
altered
severity
sepsis.Alterations
microbial
metabolic
features
corresponded
Our
findings
may
help
predict
clinical
early
stage
provide
basis
exploring
new
therapies.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
13
Published: Jan. 11, 2023
Objective
Sepsis
is
the
leading
cause
of
death
in
critically
ill
patients.
The
gastrointestinal
tract
has
long
been
thought
to
play
an
important
role
pathophysiology
sepsis.
Antibiotic
therapy
can
reduce
a
patient’s
commensal
bacterial
population
and
raise
their
risk
developing
subsequent
illnesses,
where
gut
microbiota
dysbiosis
may
be
key
factor.
Methods
In
this
study,
we
analyzed
16S
rRNA
fecal
samples
from
both
healthy
people
patients
with
sepsis
determine
if
alterations
bacteria
are
associated
Then,
developed
mouse
model
using
cecal
ligation
puncture
(CLP)
order
examine
effects
transplantation
(FMT)
short-chain
fatty
acids
(SCFAs)
on
survival
rate,
systemic
inflammatory
response,
microbiota,
mucosal
barrier
function.
Results
patients’
composition
significantly
differed
that
people.
At
phylum
level,
amount
Proteobacteria
intestinal
flora
was
much
larger
than
control
group,
whereas
number
Firmicutes
lower.
Mice
disorders
(ANC
group)
were
found
have
elevated
death,
inflammation,
organ
failure
as
compared
CLP
mice.
However,
all
these
could
reversed
by
FMT
SCFAs.
SCFAs
regulate
abundance
such
Firmicutes,
Proteobacteria,
Escherichia
Shigella,
Lactobacillus,
restoring
them
levels
comparable
those
addition,
they
increased
expression
Occludin
protein
colon
mice
sepsis,
downregulated
NLRP3
GSDMD-N
proteins,
reduced
release
factors
IL-1β
IL-18
inhibit
cell
pyroptosis,
ultimately
playing
protective
Disccusion
provide
microbe-related
benefit
suggesting
viable
treatment
for
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
13(21)
Published: Jan. 20, 2024
The
human
gut
extracts
nutrients
from
the
diet
while
forming
largest
barrier
against
outer
environment.
In
addition,
actively
maintains
homeostasis
through
intricate
interactions
with
microbes,
immune
system,
enteric
nervous
and
other
organs.
These
influence
digestive
health
and,
furthermore,
play
crucial
roles
in
systemic
disease.
Given
its
primary
role
absorbing
metabolizing
orally
administered
drugs,
there
is
significant
interest
development
of
preclinical
vitro
model
systems
that
can
accurately
emulate
intestine
vivo.
A
gut-on-a-chip
system
holds
great
potential
as
a
testing
screening
platform
because
ability
to
physiological
aspects
vivo
tissues
expandability
incorporate
combine
This
review
aims
identify
key
features
need
be
incorporated
build
more
accurate
models
highlights
recent
progress
competing
technologies
toward
building
physiologically
relevant
systems.
Furthermore,
various
efforts
construct
multi-organ
gut,
called
gut-organ-axis-on-a-chip
models,
are
discussed.
relevance
provide
valuable
platforms
for
bridging
gap
between
clinical
studies.
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: April 19, 2024
All
microorganisms
like
bacteria,
viruses
and
fungi
that
reside
within
a
host
environment
are
considered
microbiome.
The
number
of
bacteria
almost
equal
human
cells,
however,
the
genome
these
may
be
100
times
larger
than
genome.
Every
aspect
physiology
health
can
influenced
by
microbiome
living
in
various
parts
our
body.
Any
imbalance
composition
or
function
is
seen
as
dysbiosis.
Different
types
dysbiosis
corresponding
symptoms
depend
on
site
microbial
imbalance.
contribution
intestinal
extra-intestinal
microbiota
to
influence
systemic
activities
through
interplay
between
different
axes.
Whole
body
complex
process
involving
gut
non-gut
related
It
still
at
stage
infancy
has
not
yet
been
fully
understood.
Dysbiosis
genetic
factors,
lifestyle
habits,
diet
including
ultra-processed
foods
food
additives,
well
medications.
associated
with
many
diseases
cannot
diagnosed
standard
blood
tests
investigations.
Microbiota
derived
metabolites
analyzed
useful
management
addressed
altering
proper
modulation.
effect
interventions
humans
depends
beneficial
alteration
mostly
based
animal
studies
evolving
evidence
from
studies.
There
tremendous
potential
for
diagnosis,
treatment,
prognosis
diseases,
as,
monitoring
disease
humans.
system-based
approach
diagnosis
better
pure
taxonomic
approach.
could
new
therapeutic
target
conditions.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 20, 2025
Abstract
Endotoxin-driven
systemic
immune
activation
is
a
common
hallmark
across
various
clinical
conditions.
During
acute
critical
illness,
elevated
plasma
lipopolysaccharide
triggers
non-specific
activation.
In
addition,
compositional
shift
in
the
gut
microbiota,
including
an
increase
gut-luminal
opportunistic
pathogens,
observed.
Whether
causal
link
exists
between
endotoxemia
and
abundance
of
pathogens
incompletely
understood.
Here,
we
model
acute,
pathophysiological
concentrations
mice
show
that
exposure
promotes
100–10’000-fold
expansion
Klebsiella
pneumoniae
,
Escherichia
coli
Enterococcus
faecium
Salmonella
Typhimurium
within
one
day,
without
overt
enteropathy.
Mechanistically,
this
driven
by
Toll-like
receptor
4-dependent
oxygen
species
levels,
which
transiently
halts
microbiota
fermentation
fuels
growth
facultative
anaerobic
through
oxidative
respiration.
Thus,
perturbs
homeostasis
favours
potentially
increasing
risk
infection
critically
ill
patients.
Intensive Care Medicine Experimental,
Journal Year:
2023,
Volume and Issue:
11(1)
Published: Feb. 3, 2023
Abstract
Background
The
human
gastrointestinal
tract
harbours
a
complex
multi-kingdom
community
known
as
the
microbiome.
Dysbiosis
refers
to
its
disruption
and
is
reportedly
extreme
in
acute
critical
illness
yet
clinical
implications
are
unresolved.
review
systematically
evaluates
association
between
gut
dysbiosis
outcomes
of
patients
early
illness.
Methods
Following
PRISMA
guidelines,
prospectively
registered
search
was
undertaken
MEDLINE
Cochrane
databases
for
observational
studies
undertaking
metagenomic
sequencing
lower
critically
ill
adults
children
within
72
h
admission.
Eligible
reported
an
alpha
diversity
metric
one
or
more
primary
outcome,
in-hospital
mortality,
secondary
outcomes.
After
aggregate
data
were
requested,
meta-analysis
performed
four
with
mortality
stratified
high
low
Shannon
index.
Results
identified
26
systematic
4
had
suitable
meta-analysis.
No
effect
seen
on
after
binary
transformation
index
(odds
ratio
0.52,
CI
0.12–4.98,
I
2
=
0.64)
however
certainty
evidence
low.
Pathogen
dominance
commensal
depletion
each
frequently
associated
adverse
ecological
sequelae,
particularly
overabundance
Enterococcus
.
Conclusions
There
paucity
large,
rigorous
this
population.
Globally,
dynamically
reduced
ICU
admission
not
mortality.
abundance
taxa
such
spp.
appears
offer
greater
predictive
capacity
important
Annals of Intensive Care,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Aug. 1, 2024
Abstract
Background
Inflammation
is
the
hallmark
of
critical
illness
and
triggers
neuro-endocrine
stress
response
an
oxidative
stress.
Acute
inflammation
initially
essential
for
patient’s
survival.
However,
ongoing
or
exaggerated
inflammation,
due
to
persistent
organ
dysfunction,
immune
dysfunction
poor
resolution,
associated
subsequent
hypermetabolism
hypercatabolism
that
severely
impact
short
long-term
functional
status,
autonomy,
as
well
health-related
costs.
Modulation
thus
tempting,
with
goal
improve
short-
outcomes
critically
ill
patients.
Findings
can
be
modulated
by
nutritional
strategies
(including
timing
enteral
nutrition
initiation,
provision
some
specific
macronutrients
micronutrients,
use
probiotics)
metabolic
treatments.
The
most
interesting
seem
n-3
polyunsaturated
fatty
acids,
vitamin
D,
antioxidant
micronutrients
propranolol,
given
their
safety,
accessibility
clinical
use,
benefits
in
studies
context
care.
optimal
doses,
route
administration
are
still
unknown
them.
Furthermore,
recovery
phase
not
studied
defined.
Conclusion
rationale
modulation
obvious,
based
on
pathophysiology
increasingly
described
effects
pharmacological
strategies.
Regretfully,
there
isn’t
always
substantial
proof
from
research
regarding
positive
impacts
directly
brought
about
modulation.
Some
arguments
come
performed
severe
burn
patients,
but
such
results
should
transposed
non-burn
patients
caution.
Further
needed
explore
how
after
a
illness.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(23), P. 15913 - 15913
Published: Nov. 29, 2022
(1)
Background:
A
clinical
laboratory
index
to
assess
gut
dysbiosis
is
the
F/B
ratio
<
0.8.
In
fact,
an
elevated
proportion
of
Firmicutes
and
a
reduced
population
Bacteroides
in
diabetes
type
2
(T2D)
subjects
has
been
observed.
This
study
aimed
detail
status
Italian
population,
focusing
on
some
pathogenic
spectra
or
metabolic
disorders.
(2)
Material
methods:
quantity
334
fecal
samples
was
analyzed
order
perform
genetic
testing
sequencing.
(3)
Results:
trend
over
imbalance
observed
percentage
Proteobacteria
(median
value:
6.75%;
interquartile
range
(IQR):
3.57−17.29%).
statistically
significant
association
(χ2p
=
0.033)
between
T2D,
corresponding
Odds
Ratio
(OR)
1.86.
It
noted
that
females
with
cystitis/candidiasis
are
significantly
prevalent
T2D
patients
(p
0.01;
OR:
3.59;
95%
CI:
1.43−8.99).
Although,
non-diabetic
males,
sugar
craving
associated
rate
males
0.05;
OR
1.07;
CI
1.00−1.16).
(4)
Conclusion:
patients,
Bacteroidetes/Firmicutes
biased
favor
Proteobacteria,
be
expected
due
nutritional
habits
patients.
Thus,
had
altered
permeability
favoring
development
infections
vaginal
tract.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2023,
Volume and Issue:
64(23), P. 8325 - 8345
Published: April 10, 2023
Human
milk
oligosaccharides
(hMOs)
in
mothers'
play
a
crucial
role
guiding
the
colonization
of
microbiota
and
gut-immune
barrier
development
infants.
Non-digestible
carbohydrates
(NDCs)
such
as
synthetic
single
hMOs,
galacto-oligosaccharides
(GOS),
inulin-type
fructans
pectin
oligomers
have
been
added
to
infant
formula
substitute
some
hMOs'
functions.
HMOs
NDCs
can
modulate
barrier,
which
is
multiple-layered
functional
unit
consisting
microbiota,
mucus
layer,
gut
epithelium,
immune
system.
There
increasing
evidence
that
structures
complex
polysaccharides
may
influence
their
efficacy
modulating
barrier.
This
review
focuses
on
different
individual
hMOs
commonly
applied
formulas
(i)
direct
regulation
microbiota-independent
manner
(ii)
modulation
composition
microbial
metabolites
these
microbiota-dependent
manner.
Both
shown
be
essential
for
an
adequate
but
effects
are
very
dependent
structural
features
hMO
or
NDC.
knowledge
might
lead
tailored
specific
target
groups.